BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25603286)

  • 1. (Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds.
    Matzner D; Mayer G
    J Med Chem; 2015 Apr; 58(8):3275-86. PubMed ID: 25603286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riboswitch-based antibacterial drug discovery using high-throughput screening methods.
    Penchovsky R; Stoilova CC
    Expert Opin Drug Discov; 2013 Jan; 8(1):65-82. PubMed ID: 23163232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riboswitches: discovery of drugs that target bacterial gene-regulatory RNAs.
    Deigan KE; Ferré-D'Amaré AR
    Acc Chem Res; 2011 Dec; 44(12):1329-38. PubMed ID: 21615107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel targets for antibiotics discovery: riboswitches].
    Jia DF; Jia DF; Jia DF
    Yao Xue Xue Bao; 2013 Sep; 48(9):1361-8. PubMed ID: 24358767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial lysine analogs that target lysine riboswitches.
    Blount KF; Wang JX; Lim J; Sudarsan N; Breaker RR
    Nat Chem Biol; 2007 Jan; 3(1):44-9. PubMed ID: 17143270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riboswitch control of aminoglycoside antibiotic resistance.
    Jia X; Zhang J; Sun W; He W; Jiang H; Chen D; Murchie AI
    Cell; 2013 Jan; 152(1-2):68-81. PubMed ID: 23332747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The promise of riboswitches as potential antibacterial drug targets.
    Lünse CE; Schüller A; Mayer G
    Int J Med Microbiol; 2014 Jan; 304(1):79-92. PubMed ID: 24140145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dynamic nature of RNA as key to understanding riboswitch mechanisms.
    Haller A; Soulière MF; Micura R
    Acc Chem Res; 2011 Dec; 44(12):1339-48. PubMed ID: 21678902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using sequence-specific oligonucleotides to inhibit bacterial rRNA.
    Trylska J; Thoduka SG; Dąbrowska Z
    ACS Chem Biol; 2013; 8(6):1101-9. PubMed ID: 23631412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in developing small molecules targeting RNA.
    Guan L; Disney MD
    ACS Chem Biol; 2012 Jan; 7(1):73-86. PubMed ID: 22185671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of structure-based design to antibacterial drug discovery.
    Cain R; Narramore S; McPhillie M; Simmons K; Fishwick CW
    Bioorg Chem; 2014 Aug; 55():69-76. PubMed ID: 24962384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and antimicrobial action of purine analogues that bind Guanine riboswitches.
    Kim JN; Blount KF; Puskarz I; Lim J; Link KH; Breaker RR
    ACS Chem Biol; 2009 Nov; 4(11):915-27. PubMed ID: 19739679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial DNA replication enzymes as targets for antibacterial drug discovery.
    Sanyal G; Doig P
    Expert Opin Drug Discov; 2012 Apr; 7(4):327-39. PubMed ID: 22458504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The adenine riboswitch: a new gene regulation mechanism].
    Lemay JF; Lafontaine DA
    Med Sci (Paris); 2006 Dec; 22(12):1053-9. PubMed ID: 17156726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H; Sass P
    Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a 1,4-disubstituted 1,2,3-triazole binding to T box antiterminator RNA.
    Zhou S; Means JA; Acquaah-Harrison G; Bergmeier SC; Hines JV
    Bioorg Med Chem; 2012 Feb; 20(3):1298-302. PubMed ID: 22230198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riboswitches as antibacterial drug targets.
    Blount KF; Breaker RR
    Nat Biotechnol; 2006 Dec; 24(12):1558-64. PubMed ID: 17160062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unconventional screening approaches for antibiotic discovery.
    Farha MA; Brown ED
    Ann N Y Acad Sci; 2015 Sep; 1354():54-66. PubMed ID: 26100135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence assays for monitoring RNA-ligand interactions and riboswitch-targeted drug discovery screening.
    Liu J; Zeng C; Zhou S; Means JA; Hines JV
    Methods Enzymol; 2015; 550():363-83. PubMed ID: 25605395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of SBDD to the discovery of new antibacterial drugs.
    Finn J
    Methods Mol Biol; 2012; 841():291-319. PubMed ID: 22222458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.